Nn1436-4479
Research payments
$1,629,894
Through program year 2022, $1,629,894 in research payments was reported against Nn1436-4479, across 9,369 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $595,941 | 1,812 |
| 2021 | Research | $1,033,878 | 7,556 |
| 2020 | Research | $75 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ildiko Lingvay Dallas, TX Named on 1,697 payments
- Julio Rosenstock Dallas, TX Named on 503 payments
- Mark Warren Greenville, NC Named on 434 payments
- Neil Fraser Troy, MI Named on 423 payments
- Mercedes Samson Buena Park, CA Named on 406 payments
- Arvind Krishna Canton, OH Named on 383 payments
- Timothy Webb Bellbrook, OH Named on 346 payments
- Timothy Bailey Escondido, CA Named on 336 payments
- David Doriguzzi Lancaster, CA Named on 334 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.